Toluenesulfonamide intratumoral injection (PTS)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Toluenesulfonamide intratumoral injection (PTS), covering 2024-09-25 to 2024-09-25. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC With/Without Chemoimmunotherapy [Phase 3]